COVID-19 Research Uncovers Potential Treatment with Guggulsterone

Strategic Insights -

Researchers at the University of Lodz, Poland, have been investigating potential treatments for COVID-19. According to a recent study, guggulsterone, a compound found in certain plants, has shown promise as a treatment for the virus. The study, published in the journal Molecules, found that guggulsterone can bind to the ADP Ribose Phosphatase enzyme (ARP) of SARS-CoV-2, a key protein involved in the replication of the virus. This binding ability suggests that guggulsterone could be developed into a safe and effective treatment for COVID-19.

Key Takeaways:

  • The study aimed to screen herbal leads for possible inhibitors of the SARS-CoV-2 ADP Ribose Phosphatase enzyme (ARP).
  • Guggulsterone was found to be highly stabilized within the active site of the viral ARP enzyme by molecular dynamic simulation.
  • The study concluded that guggulsterone can be further used to develop a safe and competent medication for evolving therapy against SARS-CoV-2.
  • The study's results suggest that guggulsterone could be a potential treatment for COVID-19, deserving further research and development.
  • The research team, led by Mateusz Kciuk, identified other potential antiviral agents, including flavonoids, phenolic acids, and terpenoids.
  • Natural products have achieved widespread acceptance as a means of enhancing healthcare and disease prevention.
  • The study highlighted the need for further research on the use of natural products as treatments for viral infections.

Statistics:

  • 100 ns: the simulation timeframe used to evaluate the binding of guggulsterone to the ARP enzyme.
  • 11 March 2020: the date on which the World Health Organization (WHO) classified COVID-19 as a global public health hazard.
  • 2022: the year in which the study was published.
  • Molecules: the journal in which the study was published.
  • 27(8287): the volume and article number of the study in the Molecules journal.
  • https://doi.org/10.3390/molecules27238287: the DOI for the study in the Molecules journal.

Sources:

  • NewsRx. University of Lodz Researchers Target COVID-19 (Computational Bioprospecting Guggulsterone against ADP Ribose Phosphatase of SARS-CoV-2). Respiratory Therapeutics Week. December 26, 2022; p 880.
  • Molecules, 2022,27(8287):8287. (Molecules - http://www.mdpi.com/journal/molecules).
  • MDPI AG. (publisher for Molecules).
  • Mateusz Kciuk, Department of Molecular Biotechnology and Genetics, University of Lodz, 90-237 Lodz, Poland. (corresponding author).
  • Somdutt Mujwar, Isha Rani, Kavita Munjal, Adrianna Gielecinska, Renata Kontek, Kamal Shah. (additional authors).